Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Pegvisomant | The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Teneligliptin. |
| Lipoic acid | The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Teneligliptin. |
| Moxifloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Moxifloxacin. |
| Grepafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Grepafloxacin. |
| Enoxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Enoxacin. |
| Pefloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Pefloxacin. |
| Ciprofloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Ciprofloxacin. |
| Trovafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Trovafloxacin. |
| Nalidixic acid | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Nalidixic acid. |
| Rosoxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Rosoxacin. |
| Cinoxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Cinoxacin. |
| Lomefloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Lomefloxacin. |
| Gatifloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Gatifloxacin. |
| Norfloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Norfloxacin. |
| Levofloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Levofloxacin. |
| Gemifloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Gemifloxacin. |
| Ofloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Ofloxacin. |
| Sparfloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sparfloxacin. |
| Temafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Temafloxacin. |
| Fleroxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Fleroxacin. |
| Technetium Tc-99m ciprofloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Technetium Tc-99m ciprofloxacin. |
| Garenoxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Garenoxacin. |
| Nemonoxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Nemonoxacin. |
| Flumequine | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Flumequine. |
| Enrofloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Enrofloxacin. |
| Orbifloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Orbifloxacin. |
| Sarafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sarafloxacin. |
| Difloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Difloxacin. |
| Pazufloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Pazufloxacin. |
| Prulifloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Prulifloxacin. |
| Delafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Delafloxacin. |
| Sitafloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sitafloxacin. |
| Oxolinic acid | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Oxolinic acid. |
| Rufloxacin | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Rufloxacin. |
| Pipemidic acid | The therapeutic efficacy of Teneligliptin can be increased when used in combination with Pipemidic acid. |
| Methyclothiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Methyclothiazide. |
| Chlorthalidone | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Chlorthalidone. |
| Bendroflumethiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Bendroflumethiazide. |
| Metolazone | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Metolazone. |
| Benzthiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Benzthiazide. |
| Hydroflumethiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Hydroflumethiazide. |
| Indapamide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Indapamide. |
| Chlorothiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Chlorothiazide. |
| Hydrochlorothiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Hydrochlorothiazide. |
| Trichlormethiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Trichlormethiazide. |
| Polythiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Polythiazide. |
| Quinethazone | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Quinethazone. |
| Cyclopenthiazide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Cyclopenthiazide. |
| Epitizide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Epitizide. |
| Amitriptyline | Amitriptyline may decrease the hypoglycemic activities of Teneligliptin. |
| Protriptyline | Protriptyline may decrease the hypoglycemic activities of Teneligliptin. |
| Imipramine | Imipramine may decrease the hypoglycemic activities of Teneligliptin. |
| Nortriptyline | Nortriptyline may decrease the hypoglycemic activities of Teneligliptin. |
| Amoxapine | Amoxapine may decrease the hypoglycemic activities of Teneligliptin. |
| Trimipramine | Trimipramine may decrease the hypoglycemic activities of Teneligliptin. |
| Doxepin | Doxepin may decrease the hypoglycemic activities of Teneligliptin. |
| Desipramine | Desipramine may decrease the hypoglycemic activities of Teneligliptin. |
| Clomipramine | Clomipramine may decrease the hypoglycemic activities of Teneligliptin. |
| Amineptine | Amineptine may decrease the hypoglycemic activities of Teneligliptin. |
| Dimetacrine | Dimetacrine may decrease the hypoglycemic activities of Teneligliptin. |
| Butriptyline | Butriptyline may decrease the hypoglycemic activities of Teneligliptin. |
| Dosulepin | Dosulepin may decrease the hypoglycemic activities of Teneligliptin. |
| Tianeptine | Tianeptine may decrease the hypoglycemic activities of Teneligliptin. |
| Oxaprotiline | Oxaprotiline may decrease the hypoglycemic activities of Teneligliptin. |
| Opipramol | Opipramol may decrease the hypoglycemic activities of Teneligliptin. |
| Amitriptylinoxide | Amitriptylinoxide may decrease the hypoglycemic activities of Teneligliptin. |
| Dibenzepin | Dibenzepin may decrease the hypoglycemic activities of Teneligliptin. |
| Quinupramine | Quinupramine may decrease the hypoglycemic activities of Teneligliptin. |
| Melitracen | Melitracen may decrease the hypoglycemic activities of Teneligliptin. |
| Lofepramine | Lofepramine may decrease the hypoglycemic activities of Teneligliptin. |
| Iprindole | Iprindole may decrease the hypoglycemic activities of Teneligliptin. |
| Imipramine oxide | Imipramine oxide may decrease the hypoglycemic activities of Teneligliptin. |
| Glimepiride | Teneligliptin may increase the hypoglycemic activities of Glimepiride. |
| Acetohexamide | Teneligliptin may increase the hypoglycemic activities of Acetohexamide. |
| Chlorpropamide | Teneligliptin may increase the hypoglycemic activities of Chlorpropamide. |
| Tolazamide | Teneligliptin may increase the hypoglycemic activities of Tolazamide. |
| Glyburide | Teneligliptin may increase the hypoglycemic activities of Glyburide. |
| Glipizide | Teneligliptin may increase the hypoglycemic activities of Glipizide. |
| Gliclazide | Teneligliptin may increase the hypoglycemic activities of Gliclazide. |
| Tolbutamide | Teneligliptin may increase the hypoglycemic activities of Tolbutamide. |
| Gliquidone | Teneligliptin may increase the hypoglycemic activities of Gliquidone. |
| Glisoxepide | Teneligliptin may increase the hypoglycemic activities of Glisoxepide. |
| Glibornuride | Teneligliptin may increase the hypoglycemic activities of Glibornuride. |
| Carbutamide | Teneligliptin may increase the hypoglycemic activities of Carbutamide. |
| Metahexamide | Teneligliptin may increase the hypoglycemic activities of Metahexamide. |
| Dapagliflozin | Dapagliflozin may increase the hypoglycemic activities of Teneligliptin. |
| Canagliflozin | Canagliflozin may increase the hypoglycemic activities of Teneligliptin. |
| Leuprolide | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Leuprolide. |
| Goserelin | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Goserelin. |
| Nelfinavir | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Nelfinavir. |
| Indinavir | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Indinavir. |
| Ziprasidone | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Ziprasidone. |
| Etonogestrel | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Etonogestrel. |
| Desogestrel | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Desogestrel. |
| Olanzapine | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Olanzapine. |
| Megestrol acetate | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Megestrol acetate. |
| Clozapine | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Clozapine. |
| Levonorgestrel | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Levonorgestrel. |
| Progesterone | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Progesterone. |
| Chlorpromazine | The therapeutic efficacy of Teneligliptin can be decreased when used in combination with Chlorpromazine. |